Literature DB >> 19827118

Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth.

Yu-Tzu Huang1, Mei-Ying Liu, Ching-Hwa Tsai, Te-Huei Yeh.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is associated with Epstein-Barr virus (EBV) infection. We previously found that interleukin (IL)-1alpha and IL-1beta significantly increased in NPC tissues. This study investigated what EBV-encoded proteins were involved in such IL-1 production. METHODS AND
RESULTS: IL-1alpha and IL-1beta messenger ribonucleic acids (mRNAs) were detected in the EBV latent membrane protein 1 (LMP1) transfectant (LMP135) only by reverse transcriptase-polymerase chain reaction (RT-PCR). LMP1-mediated IL-1alpha and IL-1beta production could be enhanced by tumor necrosis factor alpha (TNF-alpha), determined by enzyme-linked immunosorbent assay (ELISA). Moreover, IL-1alpha and IL-1beta mRNAs and proteins were increased in a dose-dependent manner in epithelial cells transiently transfected by an LMP1 plasmid. Besides, immortalized human epidermal keratinocyte (RHEK-1) epithelial cells could be enhanced to proliferate by IL-1alpha and IL-1beta determined by water-soluble tetrazolium salt (WST-1) assay.
CONCLUSIONS: EBV LMP1 is capable of upregulating IL-1alpha and IL-1beta secretions from epithelial cells and positively modulated by TNF-alpha. This may consequently contribute to tumor growth in patients with NPC. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19827118     DOI: 10.1002/hed.21270

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.

Authors:  Shu-Chun Tsai; Sue-Jane Lin; Cheau-Jye Lin; Ya-Ching Chou; Jiun-Han Lin; Te-Huei Yeh; Mei-Ru Chen; Li-Min Huang; Meng-You Lu; Ya-Chi Huang; Huan-Yun Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

2.  Pre-treatment serum inflammatory cytokines as survival predictors of patients with nasopharyngeal carcinoma receiving chemoradiotherapy.

Authors:  Adel F Al-Kholy; Omminea A Abdullah; Mamdouh Z Abadier; Manal M Hassaan; Mohamed F Shindy; Dalia M Nor El-Dien; Ali Hasaneen
Journal:  Mol Clin Oncol       Date:  2016-09-30

3.  Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma.

Authors:  Lih-Chyang Chen; Li-Jie Wang; Nang-Ming Tsang; David M Ojcius; Chia-Chun Chen; Chun-Nan Ouyang; Chuen Hsueh; Ying Liang; Kai-Ping Chang; Chiu-Chin Chen; Yu-Sun Chang
Journal:  EMBO Mol Med       Date:  2012-10-15       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.